+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Malaria Rapid Diagnostic Devices Market 2020-2024

  • PDF Icon

    Report

  • 120 Pages
  • February 2020
  • Region: Global
  • TechNavio
  • ID: 5004488
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Global Malaria Rapid Diagnostic Devices Market 2020-2024.

The publisher has been monitoring the global malaria rapid diagnostic devices market and it is poised to grow by USD 111.63 bn during 2020-2024, progressing at a CAGR of 5% during the forecast period. The report on the global malaria rapid diagnostic devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing incidence of malaria. In addition, product launches is anticipated to boost the growth of the global malaria rapid diagnostic devices market as well.

Market Segmentation

The global malaria rapid diagnostic devices market is segmented as below:

Product:
  • Consumables
  • Systems

Geographic Segmentation:
  • North America
  • Europe
  • Asia
  • ROW

Key Trends for global malaria rapid diagnostic devices market growth

This study identifies product launches as the prime reasons driving the global malaria rapid diagnostic devices market growth during the next few years.

Prominent vendors in global malaria rapid diagnostic devices market

The publisher a detailed analysis of around 25 vendors operating in the global malaria rapid diagnostic devices market, including some of the vendors such as Abbott Laboratories, Atomo Diagnostics, bioMérieux SA, Bio-Rad Laboratories Inc., BIOSYNEX SA, Drucker Diagnostics, ERADA Technology Alliance, Omega Diagnostics Group Plc, QIAGEN N.V. and SD Biosensor Inc.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Table of Contents

Executive Summary
  • Market Overview

Market Landscape
  • Market ecosystem
  • Value chain analysis

Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product
  • Market segments
  • Comparison by Product placement
  • Consumables - Market size and forecast 2019-2024
  • Systems - Market size and forecast 2019-2024
  • Market opportunity by Product

Customer landscape
  • Overview

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • ROW - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • North America - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography

Drivers, Challenges, and Trends
  • Market drivers
  • Volume driver - Demand led growth
  • Volume driver - Supply led growth
  • Volume driver - External factors
  • Volume driver - Demand shift in adjacent markets
  • Price driver - Inflation
  • Price driver - Shift from lower to higher priced units
  • Market challenges
  • Market trends

Vendor Landscape
  • Overview
  • Landscape disruption

Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • Atomo Diagnostics
  • bioMérieux SA
  • Bio-Rad Laboratories Inc.
  • BIOSYNEX SA
  • Drucker Diagnostics
  • ERADA Technology Alliance
  • Omega Diagnostics Group Plc
  • QIAGEN N.V.
  • SD Biosensor Inc.

Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits
1. Key Finding 1
2. Key Finding 2
3. Key Finding 3
4. Key Finding 5
5. Key Finding 6
6. Key Finding 7
7. Key Finding 8
8. Market in focus
9. Parent market
10. Market characteristics
11. Product/Service portfolio of key vendors included in the market definition
12. Market segments
13. Global - Market size and forecast 2019 - 2024 ($ billion)
14. Global market: Year-over-year growth 2019 - 2024 (%)
15. Five forces analysis 2019 & 2024
16. Bargaining power of buyers
17. Bargaining power of suppliers
18. Threat of new entrants
19. Threat of substitutes
20. Threat of rivalry
21. Market condition - Five forces 2019
22. Product placement - Market share 2019-2024 (%)
23. Comparison by Product placement
24. Consumables - Market size and forecast 2019-2024 ($ billion)
25. Consumables - Year-over-year growth 2019-2024 (%)
26. Systems - Market size and forecast 2019-2024 ($ billion)
27. Systems - Year-over-year growth 2019-2024 (%)
28. Market opportunity by Product
29. Customer landscape
30. Market share by geography 2019-2024 (%)
31. Geographic comparison
32. ROW - Market size and forecast 2019-2024 ($ billion)
33. ROW - Year-over-year growth 2019-2024 (%)
34. Asia - Market size and forecast 2019-2024 ($ billion)
35. Asia - Year-over-year growth 2019-2024 (%)
36. Europe - Market size and forecast 2019-2024 ($ billion)
37. Europe - Year-over-year growth 2019-2024 (%)
38. North America - Market size and forecast 2019-2024 ($ billion)
39. North America - Year-over-year growth 2019-2024 (%)
40. Key leading countries
41. Market opportunity by geography ($ billion)
42. Impact of drivers and challenges
43. Vendor landscape
44. Landscape disruption
45. Industry risks
46. Vendors covered
47. Market positioning of vendors
48. Abbott Laboratories - Overview
49. Abbott Laboratories - Business segments
50. Abbott Laboratories - Key offerings
51. Abbott Laboratories - Key customers
52. Abbott Laboratories - Segment focus
53. Atomo Diagnostics - Overview
54. Atomo Diagnostics - Product and service
55. Atomo Diagnostics - Key offerings
56. Atomo Diagnostics - Key customers
57. Atomo Diagnostics - Segment focus
58. bioMérieux SA - Overview
59. bioMérieux SA - Business segments
60. bioMérieux SA - Key offerings
61. bioMérieux SA - Key customers
62. bioMérieux SA - Segment focus
63. Bio-Rad Laboratories Inc. - Overview
64. Bio-Rad Laboratories Inc. - Business segments
65. Bio-Rad Laboratories Inc. - Key offerings
66. Bio-Rad Laboratories Inc. - Key customers
67. Bio-Rad Laboratories Inc. - Segment focus
68. BIOSYNEX SA - Overview
69. BIOSYNEX SA - Product and service
70. BIOSYNEX SA - Key offerings
71. BIOSYNEX SA - Key customers
72. BIOSYNEX SA - Segment focus
73. Drucker Diagnostics - Overview
74. Drucker Diagnostics - Product and service
75. Drucker Diagnostics - Key offerings
76. Drucker Diagnostics - Key customers
77. Drucker Diagnostics - Segment focus
78. ERADA Technology Alliance - Overview
79. ERADA Technology Alliance - Product and service
80. ERADA Technology Alliance - Key offerings
81. ERADA Technology Alliance - Key customers
82. ERADA Technology Alliance - Segment focus
83. Omega Diagnostics Group Plc - Overview
84. Omega Diagnostics Group Plc - Business segments
85. Omega Diagnostics Group Plc - Key offerings
86. Omega Diagnostics Group Plc - Key customers
87. Omega Diagnostics Group Plc - Segment focus
88. QIAGEN N.V. - Overview
89. QIAGEN N.V. - Business segments
90. QIAGEN N.V. - Key offerings
91. QIAGEN N.V. - Key customers
92. QIAGEN N.V. - Segment focus
93. SD Biosensor Inc. - Overview
94. SD Biosensor Inc. - Product and service
95. SD Biosensor Inc. - Key offerings
96. SD Biosensor Inc. - Key customers
97. SD Biosensor Inc. - Segment focus
98. Currency conversion rates for US$
99. Research Methodology
100. Validation techniques employed for market sizing
101. Information sources
102. List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global malaria rapid diagnostic devices market: Abbott Laboratories, Atomo Diagnostics, bioMérieux SA, Bio-Rad Laboratories Inc., BIOSYNEX SA, Drucker Diagnostics, ERADA Technology Alliance, Omega Diagnostics Group Plc, QIAGEN N.V. and SD Biosensor Inc.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is the product launches."

According to the report, one of the major drivers for this market is the growing incidence of malaria.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Atomo Diagnostics
  • bioMérieux SA
  • Bio-Rad Laboratories Inc.
  • BIOSYNEX SA
  • Drucker Diagnostics
  • ERADA Technology Alliance
  • Omega Diagnostics Group Plc
  • QIAGEN N.V.
  • SD Biosensor Inc.